The Role of Somatostatin Receptors in Neuroendocrine Tumor Diagnosis
Most NETs go undetected on standard imaging. Dr. Siegel explains how somatostatin receptor biology gives clinicians a molecular target for diagnosis.
United Theranostics Is Redefining Cancer Treatment Through Precision Radiopharmaceutical Therapy
United Theranostics Featured in Meditech Today
United Theranostics was recently highlighted by Meditech Today for its pioneering work in advanced cancer care. The article showcases our leadership in targeted radiopharmaceutical therapy and molecular imaging, emphasizing our mission to deliver precise, personalized treatment options for patients with metastatic and thyroid cancers.
Read how United Theranostics is redefining cancer treatment and improving patient outcomes through innovation and compassion.
